Coming back: Autophagy in cachexia

Current Opinion in Clinical Nutrition and Metabolic Care

Volumn 17, Issue 3, 2014, Pages 241-246

  Penna, Fabio ^a   Baccino, Francesco M ^a   Costelli, Paola ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

aging; autophagy; cachexia; cancer; COPD; lysosomal proteolysis; muscle wasting

Indexed keywords

ATROGIN 1; BECLIN 1; BONE MORPHOGENETIC PROTEIN; CALPASTATIN; CATHEPSIN B; CATHEPSIN L; GLUCOCORTICOID; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; MAMMALIAN TARGET OF RAPAMYCIN; MESSENGER RNA; MUSCLE PROTEIN; PROTEASOME; PROTEIN P62; UBIQUITIN;

AGING; AUTOPHAGOSOME; AUTOPHAGY; CACHEXIA; CANCER PATIENT; CELL SURVIVAL; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE ASSOCIATION; ENERGY BALANCE; ENZYME ACTIVITY; HUMAN; LYSOSOME; MACROAUTOPHAGY; MAMMAL CELL; MICROAUTOPHAGY; MITOPHAGY; MUSCLE ATROPHY; MUSCLE DENERVATION; MUSCLE MASS; MYOPATHY; NONHUMAN; PATHOGENESIS; PEXOPHAGY; PROTEIN DEGRADATION; PROTEIN SYNTHESIS; REVIEW; SEPSIS; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; ANIMAL; METABOLISM; MUSCULAR ATROPHY; NEOPLASM; PATHOPHYSIOLOGY; WASTING SYNDROME;

AGING; ANIMALS; AUTOPHAGY; CACHEXIA; HUMANS; LYSOSOMES; MUSCULAR ATROPHY; NEOPLASMS; PROTEASOME ENDOPEPTIDASE COMPLEX; WASTING SYNDROME;

EID: 84898542075     PISSN: 13631950     EISSN: 14736519     Source Type: Journal    
DOI: 10.1097/MCO.0000000000000048     Document Type: Review

References (22)

1. Muscaritoli M, Anker SD, Argiles J, et al. Consensus definition of sarcopenia, cachexia and precachexia: joint document elaborated by Special Interest Groups (SIG) 'cachexia-anorexia in chronic wasting diseases' and 'nutrition in geriatrics'. Clin Nutr 2010; 29:154-159.
2. Sandri M. Protein breakdown in muscle wasting: role of autophagy-lysosome and ubiquitin-proteasome. Int J Biochem Cell Biol 2013; 45:2121- 2129.
3. Sartori R, Schirwis E, Blaauw B, et al. BMP signaling controls muscle mass. Nat Genet 2013; 45:1309-1318.
4. Winbanks CE, Chen JL, Qian H, et al. The bone morphogenetic protein axis is a positive regulator of skeletal muscle mass. J Cell Biol 2013; 203:345- 357.
5. Costelli P, Reffo P, Penna F, et al. Ca(2)-dependent proteolysis in muscle wasting. Int J Biochem Cell Biol 2005; 37:2134-2146.
6. Bonaldo P, Sandri M. Cellular and molecular mechanisms of muscle atrophy. Dis Model Mech 2013; 6:25-39.
7. Jin M, Liu X, Klionsky DJ. SnapShot: selective autophagy. Cell 2013; 152:368-372.
8. Lee D, Goldberg AL. SIRT1 protein, by blocking the activities of transcription factors FoxO1 and FoxO3, inhibits muscle atrophy and promotes muscle growth. J Biol Chem 2013; 288:30515-30526.
9. Wei B, Dui W, Liu D, et al. MST1, a key player, in enhancing fast skeletal muscle atrophy. BMC Biol 2013; 11:12.
10. Ljubicic V, Jasmin BJ. AMP-activated protein kinase at the nexus of therapeutic skeletal muscle plasticity in Duchenne muscular dystrophy. Trends Mol Med 2013; 19:614-624.
11. Penna F, Costamagna D, Pin F, et al. Autophagic degradation contributes to muscle wasting in cancer cachexia. Am J Pathol 2013; 182:1367- 1378.
12. Manne ND, Lima M, Enos RT, et al. Altered cardiac muscle mTOR regulation during the progression of cancer cachexia in the ApcMin/mouse. Int J Oncol 2013; 42:2134-2140.
13. Op den Kamp CM, Langen RC, Snepvangers FJ, et al. Nuclear transcription factor kappa B activation and protein turnover adaptations in skeletal muscle of patients with progressive stages of lung cancer cachexia. Am J Clin Nutr 2013; 98:738-748.
14. Tardif N, Klaude M, Lundell L, et al. Autophagic-lysosomal pathway is the main proteolytic system modified in the skeletal muscle of esophageal cancer patients. Am J Clin Nutr 2013; 98:1485-1492.
15. Langen RC, Gosker HR, Remels AH, Schols AM. Triggers and mechanisms of skeletal muscle wasting in chronic obstructive pulmonary disease. Int J Biochem Cell Biol 2013; 45:2245-2256.
16. Natanek SA, Riddoch-Contreras J, Marsh GS, et al. MuRF-1 and atrogin-1 protein expression and quadriceps fiber size and muscle mass in stable patients with COPD. COPD 2013; 10:618-624.
17. Hussain SN, Sandri M. Role of autophagy in COPD skeletal muscle dysfunction. J Appl Physiol 2013; 114:1273-1281.
18. Braun TP, Grossberg AJ, Krasnow SM, et al. Cancer- and endotoxin-induced cachexia require intact glucocorticoid signaling in skeletal muscle. FASEB J 2013; 27:3572-3582.
19. Hosokawa S, Koseki H, Nagashima M, et al. Title efficacy of phosphodiesterase 5 inhibitor on distant burn-induced muscle autophagy, microcirculation, and survival rate. Am J Physiol Endocrinol Metab 2013; 304:E922- E933.
20. Zhou J, Freeman TA, Ahmad F, et al. GSK-3alpha is a central regulator of age-related pathologies in mice. J Clin Invest 2013; 123:1821- 1832.
21. Fontes-Oliveira CC, Busquets S, Toledo M, et al. Mitochondrial and sarcoplasmic reticulum abnormalities in cancer cachexia: altered energetic efficiency? Biochim Biophys Acta 2013; 1830:2770-2778.
22. Kim KH, Kim SH, Min YK, et al. Acute exercise induces FGF21 expression in mice and in healthy humans. PLoS One 2013; 8:e63517.